全文获取类型
收费全文 | 19250篇 |
免费 | 2191篇 |
国内免费 | 5519篇 |
专业分类
26960篇 |
出版年
2024年 | 129篇 |
2023年 | 387篇 |
2022年 | 696篇 |
2021年 | 863篇 |
2020年 | 811篇 |
2019年 | 985篇 |
2018年 | 826篇 |
2017年 | 731篇 |
2016年 | 918篇 |
2015年 | 1252篇 |
2014年 | 1676篇 |
2013年 | 1612篇 |
2012年 | 1897篇 |
2011年 | 1836篇 |
2010年 | 1370篇 |
2009年 | 1226篇 |
2008年 | 1391篇 |
2007年 | 1336篇 |
2006年 | 1191篇 |
2005年 | 1094篇 |
2004年 | 914篇 |
2003年 | 816篇 |
2002年 | 720篇 |
2001年 | 476篇 |
2000年 | 395篇 |
1999年 | 291篇 |
1998年 | 212篇 |
1997年 | 179篇 |
1996年 | 123篇 |
1995年 | 88篇 |
1994年 | 68篇 |
1993年 | 53篇 |
1992年 | 57篇 |
1991年 | 41篇 |
1990年 | 34篇 |
1989年 | 36篇 |
1988年 | 37篇 |
1987年 | 17篇 |
1986年 | 16篇 |
1985年 | 23篇 |
1984年 | 23篇 |
1983年 | 12篇 |
1982年 | 28篇 |
1981年 | 15篇 |
1980年 | 6篇 |
1979年 | 8篇 |
1978年 | 4篇 |
1972年 | 6篇 |
1970年 | 5篇 |
1965年 | 4篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
992.
Bo Yang Haiqin Chen Yuanda Song Yong Q. Chen Hao Zhang Wei Chen 《Biotechnology letters》2013,35(1):75-81
The 67 kDa myosin-cross-reactive antigen (MCRA) is a member of the MCRA family of proteins present in a wide range of bacteria and was predicted to have fatty acid isomerase function. We have now characterised the catalytic activity of MCRAs from four LAB stains, including Lactobacillus rhamnosus LGG, L. plantarum ST-III, L. acidophilus NCFM and Bifidobacterium animalis subsp. lactis BB-12. MCRA genes from these strains were cloned and expressed in Escherichia coli, and the recombinant protein function was analysed with lipid profiles by GC–MS. The four MCRAs catalysed the conversion of linoleic acid and oleic acid to their respective 10-hydroxy derivatives, which suggests that MCRA proteins catalyse the first step in conjugated linoleic acid production. This is the first report of MCRA from L. rhamnosus with such catalytic function. 相似文献
993.
Minghui Xu Junmin Qian Aili Suo Hongjie Wang Xueqing Yong Xuefeng Liu Rongrong Liu 《Carbohydrate polymers》2013
To minimize the side effect of chemotherapy, a novel reduction/pH dual-sensitive drug nanocarrier, based on PEGylated dithiodipropionate dihydrazide (TPH)-modified hyaluronic acid (PEG-SS-HA copolymer), was developed for targeted delivery of doxorubicin (DOX) to hepatocellular carcinoma. The copolymer was synthesized by reductive amination via Schiff's base formation between TPH-modified HA and galactosamine-conjugated poly(ethylene glycol) aldehyde/methoxy poly(ethylene glycol) aldehyde. Conjugation of DOX to PEG-SS-HA copolymer was accomplished through the hydrazone linkage formed between DOX and PEG-SS-HA, and confirmed by FTIR and 1H NMR spectra. The polymer–DOX conjugate could self-assemble into spherical nanoparticles (∼150 nm), as indicated by TEM and DLS. In vitro release studies showed that the DOX-loaded nanoparticles could release DOX rapidly under the intracellular levels of pH and glutathiose. Cellular uptake experiments demonstrated that the nanoparticles could be efficiently internalized by HepG2 cells. These results indicate that the PEG-SS-HA copolymer holds great potential for targeted intracellular delivery of DOX. 相似文献
994.
995.
996.
997.
998.
Jingjing Ben Yan Zhang Rongmei Zhou Haiyang Zhang Xudong Zhu Xiaoyu Li Hanwen Zhang Nan Li Xiaodan Zhou Hui Bai Qing Yang Donghai Li Yong Xu Qi Chen 《The Journal of biological chemistry》2013,288(27):20076-20084
Atherosclerosis is considered a disease of chronic inflammation largely initiated and perpetuated by macrophage-dependent synthesis and release of pro-inflammatory mediators. Class A scavenger receptor (SR-A) expressed on macrophages plays a key role in this process. However, how SR-A-mediated pro-inflammatory response is modulated in macrophages remains ill defined. Here through immunoprecipitation coupled with mass spectrometry, we reported major vault protein (MVP) as a novel binding partner for SR-A. The interaction between SR-A and MVP was confirmed by immunofluorescence staining and chemical cross-linking assay. Treatment of macrophages with fucoidan, a SR-A ligand, led to a marked increase in TNF-α production, which was attenuated by MVP depletion. Further analysis revealed that SR-A stimulated TNF-α synthesis in macrophages via the caveolin- instead of clathrin-mediated endocytic pathway linked to p38 and JNK, but not ERK, signaling pathways. Importantly, fucoidan invoked an enrichment of MVP in lipid raft, a caveolin-reliant membrane structure, and enhanced the interaction among SR-A, caveolin, and MVP. Finally, we demonstrated that MVP elimination ameliorated SR-A-mediated apoptosis in macrophages. As such, MVP may fine-tune SR-A activity in macrophages which contributes to the development of atherosclerosis. 相似文献
999.
Courtney M. Tate Wayne Blosser Lisa Wyss Glenn Evans Qi Xue Yong Pan Louis Stancato 《The Journal of biological chemistry》2013,288(9):6743-6753
LY2228820 dimesylate is a highly selective small molecule inhibitor of p38α and p38β mitogen-activated protein kinases (MAPKs) that is currently under clinical investigation for human malignancies. p38 MAPK is implicated in a wide range of biological processes, in particular those that support tumorigenesis. One such process, angiogenesis, is required for tumor growth and metastasis, and many new cancer therapies are therefore directed against the tumor vasculature. Using an in vitro co-culture endothelial cord formation assay, a surrogate of angiogenesis, we investigated the role of p38 MAPK in growth factor- and tumor-driven angiogenesis using LY2228820 dimesylate treatment and by shRNA gene knockdown. p38 MAPK was activated in endothelial cells upon growth factor stimulation, with inhibition by LY2228820 dimesylate treatment causing a significant decrease in VEGF-, bFGF-, EGF-, and IL-6-induced endothelial cord formation and an even more dramatic decrease in tumor-driven cord formation. In addition to involvement in downstream cytokine signaling, p38 MAPK was important for VEGF, bFGF, EGF, IL-6, and other proangiogenic cytokine secretion in stromal and tumor cells. LY2228820 dimesylate results were substantiated using p38α MAPK-specific shRNA and shRNA against the downstream p38 MAPK effectors MAPKAPK-2 and HSP27. Using in vivo models of functional neoangiogenesis, LY2228820 dimesylate treatment reduced hemoglobin content in a plug assay and decreased VEGF-A-stimulated vascularization in a mouse ear model. Thus, p38α MAPK is implicated in tumor angiogenesis through direct tumoral effects and through reduction of proangiogenic cytokine secretion via the microenvironment. 相似文献
1000.
MicroRNA-155 (miR-155) is expressed in many cancers. It also executes evolutionary conserved functions in normal B cell development. We show that the Kaposi''s sarcoma-associated herpesvirus (KSHV) latency locus, which contains an ortholog of miR-155, miR-K12-11, complements B cell deficiencies in miR-155 knockout mice. Germinal center (GC) formation was rescued in spleen, lymph node, and Peyer''s patches. Immunoglobulin levels were restored. This demonstrates that KSHV can complement the normal, physiological function of miR-155. 相似文献